4.7 Review

The limitations and hidden gems of the epidemiology of primary biliary cirrhosis

Journal

JOURNAL OF AUTOIMMUNITY
Volume 46, Issue -, Pages 81-87

Publisher

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.jaut.2013.06.015

Keywords

Clinical epidemiology; Primary biliary cirrhosis

Categories

Ask authors/readers for more resources

Epidemiology is expected to provide important clues to our understanding of the enigmatic etiopathogenesis of primary biliary cirrhosis (PBC). First, a systematic review of population based studies indicated a wide range in the yearly incidence (0.33-5.8/100.000) and point prevalence (1.91-40.2/100.000) rates. Though different ethnic representations may also contribute it is likely that methodological issues, based on the retrospective survey of diagnosed cases, and time trend play a major role, also in view of the prolonged asymptomatic period of the disease. Of note, the highest prevalence rates (35-40/100.000) were found in areas characterized by high medical awareness and easier access to healthcare. Second, the search for serum AMA in unselected population sera may identify the largest possible number of patients who have or will develop the disease. Indeed, a surprisingly high AMA prevalence rate, ranging between 0.43 and 1%, appears likely in the general population despite the lack of adequate work-up in most studies. Third, the median female to male ratio for PBC is classically accepted as 9-10:1 but is significantly lower for AMA prevalence (2.5:1), death certificates for PBC (4.3:1) and liver transplantation (6:1), thus suggesting that PBC in men may be underdiagnosed in early stages or manifest a more severe progression. Lastly, studies of both PBC and serum AMA prevalence among family members and monozygotic twins strongly support the role played by genetic factors in the etiopathogenesis of the disease. In conclusion, PBC epidemiology is far from being a closed case and the numerous open issues will be solved through a collaborative effort and powerful data mining tools. (C) 2013 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Rheumatology

Systemic lupus erythematosus and COVID-19: what we know so far

Giuseppe. A. A. Ramirez, Luca Moroni, Emanuel Della-Torre, Maria Gerosa, Lorenzo Beretta, Enrica. P. P. Bozzolo, Lorenzo Dagna

ANNALS OF THE RHEUMATIC DISEASES (2023)

Letter Rheumatology

Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'

Maria De Santis, Antonio Voza, Victor Savevski, Salvatore Badalamenti, Maurizio Cecconi, Alberto Mantovani, Carlo Selmi

ANNALS OF THE RHEUMATIC DISEASES (2023)

Article Allergy

Advanced Imaging Supports the Mechanistic Role of Autoimmunity and Plaque Rupture in COVID-19 Heart Involvement

Maria Elena Laino, Angela Ammirabile, Francesca Motta, Maria De Santis, Victor Savevski, Marco Francone, Arturo Chiti, Lorenzo Mannelli, Carlo Selmi, Lorenzo Monti

Summary: The cardiovascular system is frequently affected by COVID-19, particularly in hospitalized cases, leading to complications such as myocarditis and pulmonary embolism. Early detection through imaging techniques such as CT scan and MRI is important for prompt disease recognition and evaluation. The immune system's abnormal response is responsible for severe COVID-19 and organ-specific injury, with molecular mimicry possibly being the immunological mechanism for myocarditis in COVID-19.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2023)

Article Allergy

The Conundrum of Psoriatic Arthritis: a Pathogenetic and Clinical Pattern at the Midpoint of Autoinflammation and Autoimmunity

Rossana Scrivo, Salvatore D'Angelo, Antonio Carriero, Chiara Castellani, Fabio Massimo Perrotta, Fabrizio Conti, Matteo Vecellio, Carlo Selmi, Ennio Lubrano

Summary: Psoriatic arthritis is a chronic inflammatory disease characterized by various symptoms and comorbidities. Its pathogenesis involves both autoinflammatory and autoimmune aspects.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2023)

Article Allergy

Immunosenescence, Inflammaging, and Frailty: Role of Myeloid Cells in Age-Related Diseases

Augusto Bleve, Francesca Motta, Barbara Durante, Chiara Pandolfo, Carlo Selmi, Antonio Sica

Summary: The immune system plays a crucial role in maintaining tissue homeostasis and defending against pathogens and cancer cells. However, the aging process leads to a decline in immune function, resulting in compromised immune responses and unresolved inflammation. This contributes to a subclinical syndrome of homeostatic frailty in the elderly, making them more susceptible to immune debilitation and chronic low-grade inflammation, which in turn increase the risk of chronic and degenerative diseases. This review focuses on the age-dependent changes in myeloid populations and their impact on frailty and diseases in the elderly.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2023)

Article Rheumatology

Post-traumatic stress disorder in patients with systemic lupus erythematosus heavily affects quality of life. A cross-sectional web survey-based study

Luca Moroni, Martina Mazzetti, Giuseppe Alvise Ramirez, Simone Zuffada, Anna Ciancio, Gabriele Gallina, Nicola Farina, Enrica Bozzolo, Valentina Di Mattei, Lorenzo Dagna

Summary: This study found that Post-traumatic Stress Disorder (PTSD) is relatively common in patients with Systemic Lupus Erythematosus (SLE) and has a detrimental impact on their quality of life.

LUPUS (2023)

Article Medicine, General & Internal

Myosteatosis Is Not Associated with Complications or Survival in HCC Patients Undergoing Trans Arterial Embolization

Chiara Masetti, Nicola Pugliese, Ludovica Lofino, Francesca Colapietro, Roberto Ceriani, Ana Lleo, Dario Poretti, Vittorio Pedicini, Stella De Nicola, Guido Torzilli, Lorenza Rimassa, Alessio Aghemo, Ezio Lanza

Summary: Alterations in nutritional status, particularly sarcopenia, have been linked to poor prognosis in cirrhotic patients. The predictive value of myosteatosis, defined as fat infiltration into skeletal muscle, is not well-known. In this retrospective analysis of 151 cirrhotic patients with unresectable hepatocellular carcinoma, myosteatosis was not associated with overall survival.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Medicine, General & Internal

Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: a subgroup analysis of the SAVE-MORE randomised trial

Karolina Akinosoglou, Antigone Kotsaki, Ioanna-Maria Gounaridi, Eirini Christaki, Simeon Metallidis, Georgios Adamis, Archontoula Fragkou, Massimo Fantoni, Aggeliki Rapti, Ioannis Kalomenidis, Georgios Chrysos, Gloria Boni, Ilias Kainis, Zoi Alexiou, Francesco Castelli, Francesco Saverio Serino, Petros Bakakos, Emanuele Nicastri, Vassiliki Tzavara, Asimina Safarika, Sofia Ioannou, Lorenzo Dagna, Katerina Dimakou, Glykeria Tzatzagou, Maria Chini, Matteo Bassetti, Vasileios Kotsis, Andrea Angheben, George Tsoukalas, Carlo Selmi, Olga-Maria Spiropoulou, Michael Samarkos, Michael Doumas, Georgia Damoraki, Aikaterini Masgala, Ilias Papanikolaou, Aikaterini Argyraki, Marcantonio Negri, Konstantinos Leventogiannis, Styliani Sympardi, Nikolaos K. Gatselis, Vasileios Petrakis, Mihai G. Netea, Periklis Panagopoulos, Vissaria Sakka, George N. Dalekos, Evangelos J. Giamarellos-Bourboulis

Summary: The SAVE-MORE trial found that anakinra treatment in COVID-19 pneumonia patients with suPAR levels of 6 ng/mL or more was associated with worse outcomes compared to placebo at day 28. Subgroup analyses showed that anakinra treatment had lower odds of worse outcomes in all studied subgroups. Long-term outcomes at days 60 and 90 also favored anakinra treatment.

ECLINICALMEDICINE (2023)

Article Medicine, General & Internal

Role of systemic immunosuppression on subglottic stenosis in granulomatosis with polyangiitis: Analysis of a single-centre cohort

Luca Moroni, Laura Giudice, Marco Lanzillotta, Adriana Cariddi, Giuseppe A. Ramirez, Enrica P. Bozzolo, Bruno Germinario, Gabriele Gallina, Stefano Viscardi, Angelo Carretta, Lorenzo Dagna

Summary: This study investigates the role of immunosuppressive treatment on the risk of relapse in patients with subglottic stenosis. The results show that systemic immunosuppression can prevent the recurrence of subglottic stenosis in patients with granulomatosis with polyangiitis.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2023)

Review Oncology

Tumor-Infiltrating B Lymphocytes: Promising Immunotherapeutic Targets for Primary Liver Cancer Treatment

Giulia Milardi, Ana Lleo

Summary: Primary liver cancer is a major cause of cancer-related death. The cellular components of the tumor microenvironment (TME) have been found to play a crucial role in tumor growth. This review provides a comprehensive summary of B-cell biology and their impact on liver malignancies, as well as their potential role in new immunotherapies for primary liver cancer treatment.

CANCERS (2023)

Article Virology

Ursodeoxycholic Acid Does Not Improve COVID-19 Outcome in Hospitalized Patients

Francesca Colapietro, Giovanni Angelotti, Chiara Masetti, Dana Shiffer, Nicola Pugliese, Stella De Nicola, Francesco Carella, Antonio Desai, Monica Ormas, Marta Calatroni, Paolo Omodei, Michele Ciccarelli, Stefano Aliberti, Francesco Reggiani, Michele Bartoletti, Maurizio Cecconi, Ana Lleo, Alessio Aghemo, Antonio Voza

Summary: The impact of UDCA on COVID-19 outcomes was analyzed, and the results showed that UDCA was not associated with mortality but was associated with a lower rate of CPAP treatment.

VIRUSES-BASEL (2023)

Meeting Abstract Rheumatology

DERMATOMYOSITIS WITH SPECIFIC AUTOANTIBODIES APPEARING AFTER SARS-COV-2 INFECTION OR MRNA VACCINATION: HINTS AT A SHARED PATHOGENETIC MECHANISM

Angela Ceribelli, Francesca Motta, Nicoletta Luciano, Giacomo Maria Guidelli, Marta Caprioli, Natasa Isailovic, Matteo Vecellio, Sofia Manara, Lorenzo Monti, Marco Francone, Carlo Selmi, Maria De Santis

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (2023)

Article Rheumatology

Hepatic and pulmonary involvement in a patient with PR3-ANCA vasculitis following SARS-CoV-2 vaccination: A case report

Antonio Tonutti, Edoardo Simonetta, Anna Stainer, Giulia Suigo, Maria De Santis, Carlo Selmi, Chiara Masetti, Ana Lleo, Luigi Maria Terracciano, Stefano Aliberti, Francesco Amati

Summary: We report the first case of ANCA-associated vasculitis following Pfizer-BioNTech vaccine, with prominent liver involvement and alveolar haemorrhage. The patient developed inflammatory arthralgias and hypertransaminasaemia two weeks after vaccination. Fever and haemoptysis appeared two months later, and the patient tested positive for anti-proteinase 3 autoantibodies.

MODERN RHEUMATOLOGY CASE REPORTS (2023)

Review Infectious Diseases

Hepatitis C Virus Infection in the Elderly in the Era of Direct-Acting Antivirals: Evidence from Clinical Trials and Real Life

Nicola Pugliese, Davide Polverini, Ivan Arcari, Stella De Nicola, Francesca Colapietro, Chiara Masetti, Monica Ormas, Roberto Ceriani, Ana Lleo, Alessio Aghemo

Summary: The efficacy and safety of DAAs in the elderly population appear to be similar to that of the general population, but further research is needed to confirm this evidence.

TROPICAL MEDICINE AND INFECTIOUS DISEASE (2023)

Article Allergy

Inflammaging and Osteoarthritis

Francesca Motta, Elisa Barone, Antonio Sica, Carlo Selmi

Summary: Osteoarthritis is a prevalent disease in the elderly population, and the role of inflammaging in its development has been explored. Inflammaging affects immune response and cartilage degradation, and may serve as a potential therapeutic target.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2023)

Article Immunology

Isolation and characterisation of PR3-specific B cells and their immunoglobulin sequences

Shane Kelly, Katherine J. L. Jackson, Timothy J. Peters, Dan Suan, Christopher C. Goodnow

Summary: This study successfully identified and characterized PR3-specific B cells from the peripheral blood of patients with PR3 autoantibodies. These cells exhibited specific immunological features, suggesting that PR3 self-reactivity may occur early in B-cell development.

JOURNAL OF AUTOIMMUNITY (2024)

Article Immunology

Targeting NF-κB signaling in B cells as a potential new treatment modality for ANCA-associated vasculitis

Ana Merino-Vico, Jan Piet van Hamburg, Paul Tuijnenburg, Giulia Frazzei, Aram Al-Soudi, Carlo G. Bonasia, Boy Helder, Abraham Rutgers, Wayel H. Abdulahad, Coen A. Stegeman, Jan-Stephan Sanders, Laura Bergamaschi, Paul A. Lyons, Theo Bijma, Laura van Keep, Kirsten Wesenhagen, Aldo Jongejan, Henric Olsson, Niek de Vries, Taco W. Kuijpers, Peter Heeringa, Sander W. Tas

Summary: B lineage cells play a critical role in ANCA-associated vasculitis (AAV), and the transcription factor NF-kappa B may be a potential therapeutic target for AAV and other autoimmune diseases with prominent B cell involvement.

JOURNAL OF AUTOIMMUNITY (2024)

Article Immunology

K2P2.1 is a regulator of inflammatory cell responses in idiopathic inflammatory myopathies

Christopher Nelke, Thomas Muentefering, Derya Cengiz, Lukas Theissen, Vera Dobelmann, Christina B. Schroeter, Helena Block, Corinna Preu, Alexander P. E. Michels, Stefanie Lichtenberg, Marc Pawlitzki, Steffen Pfeuffer, Niklas Huntemann, Alexander Zarbock, Thorben Briese, Christoph Kittl, Carsten Dittmayer, Thomas Budde, Ingrid E. Lundberg, Werner Stenzel, Sven G. Meuth, Tobias Ruck

Summary: K2P2.1 plays a regulatory role in the autoimmune response of idiopathic inflammatory myopathies (IIMs), by regulating inflammatory cell response, adhesion, and transmigration in both endothelial and skeletal muscle cells. Inhibiting K2P2.1 enhances the inflammatory response, while activating K2P2.1 improves the disease course.

JOURNAL OF AUTOIMMUNITY (2024)

Article Immunology

2023 International Consensus Guidance for the use of Tripterygium Wilfordii Hook F in the treatment of active rheumatoid arthritis

Xuan Zhang, Jun Xia, Ying Jiang, David S. Pisetsky, Josef S. Smolen, Rong Mu, Shengming Dai, Michael E. Weinblatt, Tore K. Kvien, Juan Li, Thomas Doerner, Yu Zhang, Liwei Lu, Chengde Yang, Pingting Yang, Yuan Zhang, Chenchen Xu, Zhan Zhao, Peter E. Lipsky

Summary: The study suggests that TwHF may be as effective as MTX in treating active RA, and combination therapy may be more effective than monotherapy.

JOURNAL OF AUTOIMMUNITY (2024)

Article Immunology

Novel and unique rheumatoid factors cross-react with viral epitopes in COVID-19

Maya F. Amjadi, Maxwell H. Parker, Ryan R. Adyniec, Zihao Zheng, Alex M. Robbins, S. Janna Bashar, Michael F. Denny, Sara S. Mccoy, Irene M. Ong, Miriam A. Shelef

Summary: Rheumatoid factors (RFs) are polyreactive antibodies that can bind disease-specific epitopes. Recent studies have found that RFs in COVID-19 can bind novel IgG epitopes, which provides new insights into the mechanism of RFs.

JOURNAL OF AUTOIMMUNITY (2024)

Article Immunology

Risk factors for hypogammaglobulinemia and association with relapse and severe infections in ANCA-associated vasculitis: A cohort study

Johanne Liberatore, Yann Nguyen, Jerome Hadjadj, Pascal Cohen, Luc Mouthon, Xavier Puechal, Loic Guillevin, Benjamin Terrier

Summary: B-cell depletion induced by rituximab (RTX) in ANCA-associated vasculitis (AAV) can lead to decreased gammaglobulin levels, which is associated with an increased risk of relapse and severe infections. Older age, low gammaglobulin levels, and receiving pulses of methylprednisolone at induction therapy are risk factors for gammaglobulin decline.

JOURNAL OF AUTOIMMUNITY (2024)